Aclaris Therapeutics to Participate in Two February Healthcare Conferences

Core Viewpoint - Aclaris Therapeutics, Inc. is actively participating in two healthcare conferences in February 2026, showcasing its commitment to addressing immuno-inflammatory diseases through innovative product candidates [1][4]. Company Overview - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel product candidates for patients with immuno-inflammatory diseases who currently lack satisfactory treatment options [3]. - The company boasts a multi-stage portfolio of product candidates supported by a robust research and development engine [3]. Upcoming Events - On February 12, 2026, at 2:30 PM EST, Aclaris' CEO Dr. Neal Walker and senior leadership will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY [4]. - On February 26, 2026, at 8:40 AM EST, Aclaris' President and COO Hugh Davis, Ph.D. will deliver a corporate presentation during the virtual Oppenheimer 36th Annual Healthcare Life Sciences Conference [4].